Non-hemodynamic effects: Repurposing of nonselective beta-blockers in cirrhosis?

被引：5
|
作者：
Yang, Yi [1 ,2 ]
Li, Mingkai [1 ,3 ]
Luo, Jinni [1 ,3 ]
Yu, Hongsheng [1 ,3 ]
Tian, Hong [1 ,3 ]
Wang, Xing [1 ,3 ]
机构：
[1] Sun Yat Sen Univ, Dept Gastroenterol, Affiliated Hosp 3, 600 Tianhe Rd, Guangzhou 510630, Peoples R China
[2] Xizang Minzu Univ, Sch Med, Xianyang, Peoples R China
[3] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Peoples R China
来源：
PORTAL HYPERTENSION & CIRRHOSIS | 2022年 / 1卷 / 02期
基金：
中国国家自然科学基金;
关键词：
SURVIVAL;
D O I：
10.1002/poh2.22
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：153 / 156
页数：4
相关论文
共 44 条
  • [11] Beta-blockers in cirrhosis: Thank you for your attention
    Ge, Phillip S.
    Runyon, Bruce A.
    JOURNAL OF HEPATOLOGY, 2014, 61 (02) : 451 - 452
  • [12] Beta-blockers in cirrhosis: Therapeutic window or an aspirin for all?
    Ferrarese, A.
    Tsochatzis, E.
    Burroughs, A. K.
    Senzolo, M.
    JOURNAL OF HEPATOLOGY, 2014, 61 (02) : 449 - 449
  • [13] Clinical Impact of Selective and Nonselective Beta-Blockers on Survival in Patients With Ovarian Cancer
    Watkins, Jack L.
    Thaker, Premal H.
    Nick, Alpa M.
    Ramondetta, Lois M.
    Kumar, Sanjeev
    Urbauer, Diana L.
    Matsuo, Koji
    Squires, Kathryn C.
    Coleman, Robert L.
    Lutgendorf, Susan K.
    Ramirez, Pedro T.
    Sood, Anil K.
    CANCER, 2015, 121 (19) : 3444 - 3451
  • [14] Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters
    Njei, Basile
    McCarty, Thomas R.
    Garcia-Tsao, Guadalupe
    GUT, 2016, 65 (08) : 1393 - +
  • [15] Nonselective beta blockers, hepatic decompensation, and mortality in cirrhosis: A national cohort study
    Serper, Marina
    Kaplan, David E.
    Taddei, Tamar H.
    Tapper, Elliot B.
    Cohen, Jordana B.
    Mahmud, Nadim
    HEPATOLOGY, 2023, 77 (02) : 489 - 500
  • [16] Nonselective beta-blockers reduce mortality in patients with acute-on-chronic liver failure
    Kulkarni, Anand V.
    Premkumar, Madhumita
    Kumar, Karan
    Khan, Juned A.
    Gora, Baqar A.
    Tirumalle, Sowmya
    Shaik, Sameer
    Sharma, Mithun
    Gupta, Rajesh
    Reddy, Nageshwar D.
    Rao, Padaki N.
    PORTAL HYPERTENSION & CIRRHOSIS, 2022, 1 (01): : 15 - 22
  • [17] Beta-Blockers Have No Effect on Outcomes in Patients with Cirrhosis and Severe Infections
    Galbois, Arnaud
    Das, Vincent
    Thabut, Dominique
    Maury, Eric
    Ait-Oufella, Hafid
    Housset, Chantal
    Guidet, Bertrand
    HEPATOLOGY, 2011, 53 (04) : 1412 - 1413
  • [18] Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature
    Kimer, Nina
    Feineis, Martin
    Moller, Soren
    Bendtsen, Flemming
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (02) : 129 - 137
  • [19] The deleterious effects of non-selective beta-blockers on cirrhotic patients: the confused clinician!
    Trifan, Anca
    Stanciu, Carol
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2014, 23 (04) : 457 - 458
  • [20] Nonselective beta-blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States
    Wijarnpreecha, Karn
    Li, Fang
    Xiang, Yang
    Xu, Xun
    Zhu, Cong
    Maroufy, Vahed
    Wang, Qing
    Tao, Wei
    Dang, Yifang
    Huy Anh Pham
    Zhou, Yujia
    Li, Jianfu
    Zhang, Xinyuan
    Xu, Hua
    Taner, C. Burcin
    Yang, Liu
    Tao, Cui
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 481 - 492
12345